ISE and CCmar, University of Algarve, 8005-139 Faro, Portugal.
Dalton Trans. 2012 Nov 7;41(41):12749-58. doi: 10.1039/c2dt31688a. Epub 2012 Sep 12.
Recently we demonstrated that the decavanadate (V(10)) ion is a stronger Ca(2+)-ATPase inhibitor than other oxometalates, such as the isoelectronic and isostructural decaniobate ion, and the tungstate and molybdate monomer ions, and that it binds to this protein with a 1 : 1 stoichiometry. The V(10) interaction is not affected by any of the protein conformations that occur during the process of calcium translocation (i.e. E1, E1P, E2 and E2P) (Fraqueza et al., J. Inorg. Biochem., 2012). In the present study, we further explore this subject, and we can now show that the decaniobate ion, Nb(10) = Nb(10)O(28), is a useful tool in deducing the interaction and the non-competitive Ca(2+)-ATPase inhibition by the decavanadate ion V(10) = V(10)O(28). Moreover, decavanadate and vanadate induce protein cysteine oxidation whereas no effects were detected for the decaniobate, tungstate or molybdate ions. The presence of the antioxidant quercetin prevents cysteine oxidation, but not ATPase inhibition, by vanadate or decavanadate. Definitive V(IV) EPR spectra were observed for decavanadate in the presence of sarcoplasmic reticulum Ca(2+)-ATPase, indicating a vanadate reduction at some stage of the protein interaction. Raman spectroscopy clearly shows that the protein conformation changes that are induced by V(10), Nb(10) and vanadate are different from the ones induced by molybdate and tungstate monomer ions. Here, Mo and W cause changes similar to those by phosphate, yielding changes similar to the E1P protein conformation. The putative reduction of vanadium(V) to vanadium(IV) and the non-competitive binding of the V(10) and Nb(10) decametalates may explain the differences in the Raman spectra compared to those seen in the presence of molybdate or tungstate. Putting it all together, we suggest that the ability of V(10) to inhibit the Ca(2+)-ATPase may be at least in part due to the process of vanadate reduction and associated protein cysteine oxidation. These results contribute to the understanding and application of these families of mono- and polyoxometalates as effective modulators of many biological processes, particularly those associated with calcium homeostasis.
最近,我们证明了十钒酸盐(V(10))离子比其他氧代金属酸盐(如等电子和等结构的十铌酸盐离子、钨酸盐和钼酸盐单体离子)更能有效地抑制 Ca(2+)-ATP 酶,并且该离子与该蛋白的结合比为 1:1。V(10)的相互作用不受钙转运过程中发生的任何蛋白构象的影响(即 E1、E1P、E2 和 E2P)(Fraqueza 等人,J. Inorg. Biochem.,2012)。在本研究中,我们进一步探讨了这一课题,现在可以表明,十铌酸盐离子Nb(10) = Nb(10)O(28)是一种有用的工具,可以推断出十钒酸盐离子V(10) = V(10)O(28)的相互作用和非竞争性 Ca(2+)-ATP 酶抑制作用。此外,十钒酸盐和钒酸盐诱导蛋白半胱氨酸氧化,而十铌酸盐、钨酸盐或钼酸盐离子则没有这种作用。抗氧化剂槲皮素的存在可以阻止钒酸盐或十钒酸盐引起的半胱氨酸氧化,但不能阻止 ATP 酶的抑制。在肌浆网 Ca(2+)-ATP 酶存在的情况下,观察到十钒酸盐的明确的 V(IV)EPR 谱,表明在蛋白相互作用的某个阶段发生了钒酸盐的还原。拉曼光谱清楚地表明,十钒酸盐、十铌酸盐和钒酸盐诱导的蛋白构象变化与钼酸盐和钨酸盐单体离子诱导的构象变化不同。在这里,Mo 和 W 引起的变化类似于磷酸盐引起的变化,导致类似于 E1P 蛋白构象的变化。钒(V)的还原为钒(IV)和十钒酸盐和十铌酸盐的非竞争性结合可能解释了与钼酸盐或钨酸盐存在时相比拉曼光谱的差异。综合来看,我们认为十钒酸盐抑制 Ca(2+)-ATP 酶的能力可能至少部分归因于钒酸盐还原和相关蛋白半胱氨酸氧化的过程。这些结果有助于理解和应用这些单氧和多氧代金属酸盐家族作为许多生物过程的有效调节剂,特别是与钙稳态相关的过程。